COMPLETED

Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Research teams in Boston University, UCLA, and Weill Cornell will recruit 90 participants in 3 years (10 participants per site per year) and evaluate JASPER, play-based intervention, using the BOSCC and ELSA-T. Participants will be randomized to receive JASPER facilitated either by a clinician or the caregiver. After 10 weeks, the participants will be evaluated using the CGI to determine if they are "responders" or "non-responders". Nonresponders will be given a mix of clinician and caregiver-facilitated JASPER and responders will remain the course for the following 10 weeks. Coding of the BOSCC and ELSA-T will be the outcome measures and change will be evaluated throughout the study.

Official Title

Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial

Quick Facts

Study Start:2021-04-27
Study Completion:2025-10-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT04146428

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Months to 5 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Minimally verbal children eligible for the ADOS Toddler Module or Module 1 (pre or minimally verbal) or those who have emerging phrases who may receive Module 2 (phrase speech) will be enrolled. The sample will be limited to children with confirmed diagnosis and nonverbal mental ages greater than or equal to 12 months. The child must be 18 months and 5 years of age.
  1. * Children that do not have a mental age greater than or equal to 12 months, don't have a confirmed diagnosis, are under the age of 18 months and older than 5 years of age.

Contacts and Locations

Study Locations (Sites)

UCLA
Los Angeles, California, 90095-1406
United States
Semel Institute
Los Angeles, California, 90095
United States
Boston University
Boston, Massachusetts, 02215
United States
Weill Cornell Medical College/New York Presbyterian Hospital
White Plains, New York, 10605
United States

Collaborators and Investigators

Sponsor: University of California, Los Angeles

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-04-27
Study Completion Date2025-10-28

Study Record Updates

Study Start Date2021-04-27
Study Completion Date2025-10-28

Terms related to this study

Keywords Provided by Researchers

  • BOSCC
  • ELSA-T
  • JASPER
  • autism

Additional Relevant MeSH Terms

  • Autism Spectrum Disorder